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Abstract. 
 
Maintenance of cells in a quiescent state af-
ter terminal differentiation occurs through a number of 
mechanisms that regulate the activity of the E2F family 
of transcription factors. We report here that changes in 
the subcellular compartmentalization of the E2F family 
proteins are required to prevent nuclei in terminally 
differentiated skeletal muscle from reentering S phase. 
 
In terminally differentiated L6 myotubes, E2F-1, E2F-3, 
and E2F-5 were primarily cytoplasmic, E2F-2 was nu-
clear, whereas E2F-4 became partitioned between both 
compartments. In these same cells, pRB family mem-
bers, pRB, p107, and p130 were also nuclear. This com-
partmentalization of the E2F-1 and E2F-4 in differenti-
ated muscle cells grown in vitro reﬂected their observed 
subcellular location in situ. We determined further that 
exogenous E2F-1 or E2F-4 expressed in myotubes at 
levels fourfold greater than endogenous proteins com-
partmentalized identically to their endogenous coun-
terparts. Only when overexpressed at higher levels was 
inappropriate subcellular location for these proteins 
observed. At these levels, induction of the E2F-regu-
lated genes, cyclins A and E, and suppression of factors 
 
associated with myogenesis, myogenin, and p21
 
Cip1 
 
was 
observed. Only at these levels of E2F expression did 
nuclei in these terminally differentiated cells enter S 
phase. These data demonstrate that regulation of the 
subcellular compartmentalization of E2F-family mem-
bers is required to maintain nuclei in a quiescent state 
in terminally differentiated cells.
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Introduction
 
The transition from G
 
0
 
 and G
 
1
 
 into S phase is determined
by a series of factors that regulate the activity of a family
of transcription factors known collectively as E2F (for re-
view see Dyson, 1998). The E2F family proteins consist of
six members: E2F-1, E2F-2, E2F-3, E2F-4, E2F-5, and
E2F-6. All but the latter have been shown to regulate the
expression of genes involved in cell cycle progression, in-
cluding cyclins A and E (DeGregori et al., 1995; Botz et al.,
1996), 
 
E2F-1
 
 itself (Neuman et al., 1994; Smith et al.,
1996), 
 
DHFR
 
 (Slansky et al., 1993; DeGregori et al., 1995),
 
cdc2
 
 (DeGregori et al., 1995; Shimizu et al., 1995), thymi-
dine kinase (Karlseder et al., 1996), 
 
c-myc
 
 (Hiebert et al.,
1989, 1992; Thalmeier et al., 1989; Mudryj et al., 1990;
Hamel et al., 1992), 
 
HsOrc1
 
 (Ohtani et al., 1996), 
 
cdc6
 
(Leone et al., 1998; Ohtani et al., 1998), 
 
pRB
 
 (Shan et al.,
1994), and p107 (Zhu et al., 1995b).
The pRB family proteins, pRB, p107, and p130, interact
directly with and regulate the activity of the E2F family of
transcription factors (Bandara and La Thangue, 1991;
Chellappan et al., 1991; Chittenden et al., 1991; Defeo-
Jones et al., 1991; Mudryj et al., 1991; Cao et al., 1992; Co-
brinik et al., 1993; Cress et al., 1993; Helin et al., 1993; Lees
et al., 1993; Beijersbergen et al., 1994; Dynlacht et al.,
1994; Ginsberg et al., 1994; Jiang et al., 1995; Smith and
Nevins, 1995; Welch and Wang, 1995; Wolf et al., 1995;
 
Zhu et al., 1995a). These interactions and their resul-
tant growth-suppressive effects are antagonized by cyclin-
dependent kinase-mediated phosphorylation of the pRB
family proteins (Chellappan et al., 1991; Helin et al., 1992;
Hinds et al., 1992; Kaelin et al., 1992; Beijersbergen et al.,
1995; Suzuki-Takahashi et al., 1995; Mayol et al., 1996;
Xiao et al., 1996). In addition to pRB family binding, regu-
lation of E2F activity occurs by cell cycle–dependent fluc-
tuation of pRB and E2F levels (Moberg et al., 1996; Sardet
et al., 1995; Shan et al., 1994). Differences in the levels of
these two cell cycle regulatory families of proteins, as well
as the cyclins, are even more profound during embryogen-
esis, where tissue-specific expression of distinct members
of these families has been documented (Aguzzi et al.,
1996; Dagnino et al., 1997a,b; Jiang et al., 1997). This spec-
ificity is reflected by the tissue-specific effects of mice har-
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boring germline deletions of pRB, E2F, or D-cyclin family
members (Clarke et al., 1992; Jacks et al., 1992; Lee et al.,
1992; Fantl et al., 1995; Sicinski et al., 1995, 1996; Cobrinik
et al., 1996; Field et al., 1996; LeCouter et al., 1998a,b; Lin-
deman et al., 1998). The distinct expression patterns for
these cell cycle regulatory proteins are reiterated in a vari-
ety of stem cells stimulated to differentiate in cell culture
(Slack et al., 1993; Dobashi et al., 1995; Kiess et al., 1995;
Kranenburg et al., 1995; Rao and Kohtz, 1995; Shin et al.,
1995; Wang et al., 1995; LeCouter et al., 1996; Della et al.,
1997; Gill et al., 1998). During neuronal differentiation of
murine P19 embryonal carcinoma cells, for example, E2F-3
and E2F-4 levels decrease, E2F-2 levels remain constant,
and E2F-1 is induced (Gill et al., 1994). Simultaneously,
both pRB and p130 levels increase, as do the levels of their
active hypophosphorylated forms. These changes in the
pRB family protein activity are required for the strong re-
duction in free E2F transcription complexes (La Thangue
and Rigby, 1987; La Thangue et al., 1990; Shivji and La
Thangue, 1991; Corbeil et al., 1995; Gill et al., 1998), also
supported in studies demonstrating that inactivation of
pRB family proteins by viral oncoproteins inhibits termi-
nal differentiation (Caruso et al., 1993; Bishopric et al.,
1997; Slack et al., 1995). Analogous to neuronal differenti-
ation, changes in the expression pattern and activity of
these cell cycle regulatory proteins are required for dif-
ferentiation of myoblasts into multinucleated myotubes
(Corbeil et al., 1995; Kiess et al., 1995; Shin et al., 1995).
Forced expression of E2F-1 before induction of differenti-
ation inhibits formation of myotubes (Neuman et al., 1995;
Wang et al., 1995; Guy et al., 1996; Strom et al., 1998) as
does inactivation of pRB, due to mutation, loss of expres-
sion, or functional inactivation by viral oncoproteins (Wei-
gel and Nevins, 1990; Weigel et al., 1990; Braun et al.,
1992; Haider et al., 1994; Slack et al., 1995; Tedesco et al.,
1995; Novitch et al., 1996; Tiainen et al., 1996; Zacksen-
haus et al., 1996; Kobayashi et al., 1998).
Although the levels and phosphorylation state of both
the E2F and pRB families fluctuate in a cell cycle and tis-
sue-specific manner, additional mechanisms also regulate
E2F transcriptional activity. Tissue culture fibroblasts syn-
chronized by serum depletion showed cell cycle–depen-
dent translocation of E2F-4, pRB, p107, and p130 (Linde-
man et al., 1997; Muller et al., 1997; Verona et al., 1997).
E2F-4 and E2F-5 are primarily cytoplasmic in cycling cells,
due apparently to the lack of an NH
 
2
 
-terminal nuclear lo-
calization signal (NLS),
 
1
 
 this signal being present in E2F-1,
E2F-2, and E2F-3 (Lindeman et al., 1997). However, E2F-4
can be shifted to the nucleus by coexpression of binding
factors that encode NLS such as an alternatively spliced
version of the heterodimerization partner, DP-3 (de la
Luna et al., 1996; Puri et al., 1998), as well as p107 or p130
(Lindeman et al., 1997; Puri et al., 1998). The presence of
E2F-1 or E2F-4 in the nucleus of undifferentiated myo-
blasts blocks cell cycle exit and promotes progression to S
 
phase despite removal of mitogenic signals (Puri et al.,
1998).
Previous studies have demonstrated that active E2F
blocks the transition out of the cell cycle as cells terminally
differentiate. We wished to determine whether sequestra-
tion of E2F family proteins in the cytoplasm was required
to maintain cells in a quiescent state after terminal differ-
entiation. Thus, we characterized the subcellular localiza-
tion of E2F and pRB family members in terminally differ-
entiated myotubes in cells grown in cell culture and in
whole tissue. Our results demonstrate the distinct com-
partmentalization of these factors in terminally differenti-
ated cells. Furthermore, significant increases in nuclear lo-
calization of either E2F-1 or E2F-4 causes the nuclei in
terminally differentiated myotubes to enter S phase. This
inappropriate S phase entry is mediated in part by altered
expression of cell cycle regulatory factors, suggesting that
terminally differentiated myotube nuclei are competent to
respond to an E2F-mediated proliferation signal and that
cytoplasmic compartmentalization of E2F is an important
mechanism for maintaining the postmitotic state of these
nuclei.
 
Materials and Methods
 
Antibodies
 
The anti-p107 (SC-318), anti-p130 (SC-317), anti–E2F-1 (SC-193), anti–
E2F-2 (SC-633), anti–E2F-3 (SC-878), anti–E2F-4 (SC-866), anti–E2F-5
(SC-999), anti–cyclin E (SC-481), anti–cyclin A (SC-596), anti-cdk2 (SC-
163), and anti-cdk4 (SC-749) polyclonal antibodies were purchased from
Santa Cruz Biotechnology, Inc. The anti-pRB (14001A), anti-p21
 
Cip1
 
(65951A), anti-myogenin (65121A) mAbs were purchased from PharMin-
gen. Anti-bromodeoxyuridine (BrdU) mAb was purchased as part of the
BrdU labeling and detection kit I (Roche Diagnostics). Anti-hemaggluti-
nin (HA) rat mAb (1867423) was purchased from Roche Diagnostics. IF8
anti-pRB mAb was provided by B. Gallie (Princess Margaret Hospital,
Toronto, Ontario).
 
Plasmids and Adenoviral Constructs
 
Adenoviral vectors expressing full-length human E2F-1 and E2F-4 under
the control of the cytomegalovirus promoter were kindly provided by J.
DeCaprio and G. Leone (Dana Farber Cancer Institute, Boston, MA).
The pAdtrack and pAdeasy vectors (He et al., 1998), as well as BJ5183
bacterial cells were generously provided by B. Vogelstein (Johns Hopkins
University, Baltimore, MD). pEGFPC-1 (Clontech) was provided by J.
Rutka (Hospital for Sick Children, Toronto, Ontario).
For the green fluorescent protein (GFP) fusion proteins, HA-tagged
versions of human E2F-1 and E2F-4 cDNAs were subcloned in frame with
GFP in pEGFPC-1. For GFP–E2F-1 or GFP–E2F-4 fusion proteins con-
taining the simian virus 40 (SV40) NLS, oligos encoding the SV40 large T
antigen (LgT) NLS (MVPKKKRKV) were subcloned into the polylinker
between GFP and the E2F cDNA maintaining the reading frame. These
GFP-tagged recombinant cDNAs were excised from pEGFPC-1 with
Age1 (5
 
9
 
 of the GFP tag) and Hpa1 (in the SV40 polyA tail region) and
cloned into the Age1 and Hpa1 sites of pAdtrack–cytomegalovirus.
pAdtrack–cytomegalovirus constructs were linearized with PmeI and
cotransformed with pAdeasy into BJ5183 bacterial cells by electropora-
tion. Recombinant adenoviral constructs were isolated, prepared on ce-
sium chloride gradient, and transfected into 293 cells by Hepes-buffered
saline transfection. 10 d after transfection, virus was harvested by scraping
and pelleting the transfected 293 cells, followed by resuspension in sterile
PBS/10% glycerol, and three freeze–thaw cycles. The suspension was cen-
trifuged at 8,000 
 
g
 
 for 20 min at 4
 
8
 
C, and the supernatant was used to rein-
fect 1–10 100-mm plates of confluent 293 cells for 90 min at 37
 
8
 
C, in 3 ml
serum-free media. Cells were then washed twice with PBS and incubated
for 2–5 d at 37
 
8
 
C until 40–80% of cells detached from the plate. Virus was
harvested as above, and the reinfection process repeated until viral titers
as determined by plaque assay reached at least 10
 
8
 
 pfu/
 
m
 
l.
 
1
 
Abbreviations used in this paper:
 
 BrdU, bromodeoxyuridine; DAPI, 4,6-
diamidino-2-phenylindole; EMSA, electrophoretic mobility shift assay;
GFP, green fluorescent protein; HA, hemagglutinin; LgT, large T antigen;
NES, nuclear export signal(s); NLS, nuclear localization signal; SV40, sim-
ian virus 40. 
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Cell Culture
 
Rat L6 myoblasts (Yaffe, 1968) were cultured in H21 DME containing
10% FCS. Differentiation into myotubes was performed by switching con-
fluent cells into H21 DME containing 2% FCS. Rat-12 D5 cells (kindly
provided by Dr. Steve Reed, Scripps Research Institute, La Jolla, CA)
(Resnitzky et al., 1994) were grown in DME containing 10% FCS and 2
 
m
 
g/ml tetracycline, 150 
 
m
 
g/ml hygromycin, and 350 
 
m
 
g/ml G418. Induction
of cyclin D1 was achieved by switching to DME containing 0% FCS and 2
 
m
 
g/ml tetracycline for 40 h. Media were replaced with serum-free DME
containing no tetracycline for 24 h. Then media with 10% FCS were
added for the duration of the experiment. NIH 3T3 cells were cultured in
H21 DME containing 10% FCS.
L6 cells to be infected with adenoviral vectors and analyzed for BrdU
incorporation were first grown to confluence in 60-mm dishes and differ-
entiated to multinucleated myotubes in 2% FCS for 2 d. Cells were then
infected with adenovirus in 1.5 ml serum-free media for 90 min at 37
 
8
 
C,
followed by two washes in PBS and incubation at 37
 
8
 
C for 24 h. BrdU was
then added at a final concentration of 2 
 
m
 
M, and cells were incubated for a
further 48 h.
 
Flow Cytometric Analysis
 
To determine the proportion of cells present in a particular cell cycle
phase, FACS analysis of DNA content was performed as follows. Cells
were harvested at the indicated timepoints after serum addition, and cells
were fixed with 70% ice-cold ethanol for FACS analysis. The fixed
cells were suspended in 500 
 
m
 
l PBS containing 0.6% NP-40 and 0.1 mg/ml
propidium iodide, and treated with RNase at a concentration of 1 mg/ml
for 30 min. DNA fluorescence was measured in a Becton Dickinson flow
cytometer, and the percentages of cells in G
 
1
 
, S, and G
 
2
 
/M phases of the
cell cycle were determined using the CellFIT software (version 2.01.2).
 
Immunofluorescence
 
L6 and Rat-12 D5 cells grown on coverslips were rinsed twice in PBS be-
fore fixation in ice-cold 100% methanol for 3 min. Coverslips were air-
dried for 
 
z
 
1 h and stored at 
 
2
 
20
 
8
 
C. P19 cells were grown on coverslips
and rinsed twice in PBS before fixation in 4% paraformaldehyde, 0.2%
picric acid for 30 min at room temperature. Without drying out, fixed cells
were then washed twice in PBS and stored at 4
 
8
 
C in a moist chamber.
Whole embryos from pregnant BALB C mice were removed at day 18.5
(detection of a vaginal plug following being day 0.5), snap-frozen in liquid
nitrogen–cooled isopentane, and stored at 
 
2
 
80
 
8
 
C. Cryosections (6–8 
 
m
 
m)
were cut and collected on Superfrost Plus microscope slides (Fisher Scien-
tific), air-dried, and stored at 
 
2
 
80
 
8
 
C. Cells grown on coverslips to be ana-
lyzed for BrdU incorporation were washed three times in PBS and fixed
for 20 min in ice-cold 70% ethanol, 50 mM glycine, pH 2.0, at 
 
2
 
20
 
8
 
C. Cov-
erslips were then washed three times in PBS and stored at 4
 
8
 
C.
Methanol-fixed cells and embryo sections were thawed and rehydrated
for 30 min in PBS, whereas paraformaldehyde-fixed cells were used di-
rectly for immunostaining. Cells and sections were immersed in 0.1%
BSA/PBS for 30 min to block nonspecific binding. Cells were then incu-
bated with polyclonal antibody diluted 1:80 in 0.1% BSA/PBS, or 1:20 di-
luted mAb for 1 h at room temperature. Cells were washed three times
with 0.1% BSA/PBS for 5 min at room temperature and subsequently in-
cubated for 60 min at room temperature with FITC-conjugated goat anti–
mouse or goat anti–rabbit IgG (1 mg/ml, 1:20 dilution, 0.1% BSA/PBS;
Jackson ImmunoResearch). The cells were washed three times with 0.1%
BSA/PBS for 5 min at room temperature and mounted. To image the sig-
nal, conventional fluorescence microscopy was carried out with a photo-
microscope (Zeiss) equipped with an epifluorescence attachment.
BrdU incorporation was detected in ethanol-glycine–fixed BrdU-
labeled cells using a BrdU labeling kit (Roche Diagnostics) according to
the manufacturer’s instructions.
 
Electrophoretic Mobility Shift Assays
 
Nuclear lysates were prepared as described previously (Schreiber et al.,
1989). An end-labeled (
 
32
 
P[
 
g
 
-ATP]) double-stranded oligonucleotide con-
taining a single E2F binding site (5
 
9
 
-GGATTTAAGTTTCGCGCC-
CTTTCTCAA-3
 
9
 
) was used as template. 1.5 
 
m
 
g of nuclear lysates was
used in 15-
 
m
 
l reactions containing 2 
 
3
 
 10
 
4
 
 cpm of labeled DNA (
 
z
 
0.2 ng),
120 mM NaCl, 4% Ficoll, 20 mM Hepes, pH 7.9, 50 ng/
 
m
 
l salmon sperm
DNA, 2.5 mM MgCl
 
2
 
, 40 mM KCl, 1 mM EDTA, 0.1 mM EGTA, 1 mM
DTT, and 250 ng/
 
m
 
l BSA. For supershift electrophoretic mobility shift as-
says (EMSAs) or EMSAs with added glutathione 
 
S
 
-transferase fusion
proteins, reaction mixtures were incubated at room temperature for 10
min, followed by addition of 1 
 
m
 
l of mAb. These reactions were allowed to
incubate for an additional 15–20 min. The DNA–protein complexes were
then resolved on a 4.5% polyacrylamide gel in 0.25
 
3
 
 Tris-buffered EDTA
at 20 V/cm and the dried gel exposed to film for 8–48 h.
 
Western Blots
 
Whole cell or nuclear and cytoplasmic protein lysates were obtained from
both L6 cells as described previously (Schreiber et al., 1989; Kiess et al.,
1995). 20 
 
m
 
g of each lysate was run on SDS-PAGE gels and transferred to
nitrocellulose membrane (Schleicher & Schuell). Blots were blocked over-
night at 4
 
8
 
C in PBS, 0.1% Tween 20 containing 4% skim milk powder, fol-
lowed by incubation at room temperature for 1.5 h in a 1:1,000 dilution of
primary antibody. After a 45-min incubation with goat anti–rabbit or goat
anti–mouse HRP-conjugated secondary antibody (1:8,000; BioRad), blots
were developed with the ECL fluorescent detection kit according to the
manufacturer’s instructions (Amersham Pharmacia Biotech).
 
Coimmunoprecipitation Assays
 
3T3 fibroblasts were infected with adenoviral vectors expressing GFP-
tagged E2Fs at a multiplicity of infection of 300. 48 h after infection, whole
cell lysates were prepared and 400 
 
m
 
g was immunoprecipitated for 16 h at
4
 
8
 
C with 0.5 
 
m
 
g polyclonal IgG. 20 
 
m
 
l protein A–Sepharose beads were
then added and incubated for a further 2 h. Immunocomplexes were
washed five times with ice-cold NP-40 lysis buffer and separated on 7%
reducing SDS-PAGE gels. After transfer to nitrocellulose membrane,
blots were probed as described above.
 
Results
 
Compartmentalization of E2F and pRB Family Proteins 
in Quiescent Cells during a Reversible Growth Arrest
 
As a starting point in our analysis of the localization of the
pRB and E2F family proteins in terminally differentiated
cells that irreversibly enter a quiescent state (G
 
0
 
), we at-
tempted to verify their cell cycle–dependent localization in
both Rat-1 fibroblasts and L6 myoblasts. Previous reports
using a number of cell lines, such as Rat-1 cells, demon-
strated that E2F is nuclear in arrested cells and shifted to
the cytoplasm as cells progressed into S phase (Muller et al.,
1997; Verona et al., 1997). However, Fig. 1 demonstrates
that in contrast to these previous reports, serum-starved
cells arrested in G
 
0
 
 will cause localization of the E2F and
pRB family proteins to different compartments depending
on the presence of even very weak mitogenic signals. Spe-
cifically, when Rat-1 fibroblasts are made quiescent by
plating in the complete absence of serum (Fig. 1 A), pRB,
p130, E2F-1, and E2F-4 are exclusively cytoplasmic. Se-
rum stimulation and progression through the cell cycle
drives these proteins into the nucleus. Similarly, L6 myo-
blasts arrested in 0% serum also show exclusive localiza-
tion of E2F-1 and E2F-4 to the cytoplasm (Fig. 1 B, left
panel). In contrast, the cytoplasmic localization of these
factors is completely altered in quiescent cells arrested in
0.2% serum (Fig. 1 B, right panel). Specifically, E2F-1 and
E2F-4 are primarily nuclear in undifferentiated myoblasts
arrested in G
 
0
 
/G
 
1
 
 due to plating in 0.2% serum.
We hypothesized that the difference in localization in
cells in 0.2% serum was due to the cell responding to very
weak mitogenic signals in the absence of cell cycle pro-
gression. This hypothesis was tested using the Rat-1 D5
cell line (Resnitzky et al., 1994), where a cyclin D1 trans-
gene was placed under the control of the tetracycline oper- 
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ator (Gossen and Bujard, 1992). Here, we expected cyclin
D1 to provide a mitogenic signal insufficient to overcome
the cell cycle arrest imposed on these fibroblasts in the ab-
sence (0%) of serum. Comparing the localization in Fig. 1
C to the same cells in the absence of cyclin D1 induction
(Fig. 1 A, 0 h), it is evident that pRB, p130, E2F-1, and
E2F-4 are primarily nuclear (some cytoplasmic localiza-
tion is evident) despite the lack of cell cycle progression.
Thus, the dynamic regulation of pRB and E2F subcellu-
lar compartmentalization is clearly dependent on the state
of the cells and the signals impinging on them, even in a
quiescent, noncycling state. As will be made apparent be-
low, localization of E2F in cells with no serum reflects
their localization in terminally differentiated cells irrevers-
ibly arrested in G
 
0
 
.
 
E2F Family Members Are Differentially Located in 
Terminally Differentiated Cells
 
We next determined the subcellular compartmentalization
of E2F and pRB family members in differentiated multi-
nucleated L6 myotubes that are in an irreversible quies-
cent (G
 
0
 
) state (Fig. 2, A–H). By day 5 of differentiation,
the fluorescence signal for the pRB family members, pRB,
p107, and p130, coincided primarily with the signal for
the 4,6-diamidino-2-phenylindole (DAPI)-stained nuclei
in both multinucleated myotubes and undifferentiated myo-
blasts (Fig. 2, F–H). Only weak cytoplasmic localization
for the pRB family proteins was observed using immuno-
histochemistry and confirmed by Western analysis of frac-
tionated cell lysates (data not shown). In contrast to these
negative cell cycle regulatory proteins, the different E2Fs
exhibited distinct subcellular localization patterns in ter-
minally differentiated myotubes (Fig. 2, A–E). We em-
ployed anti-E2F antibodies selected for their specificity,
determined by Western analysis of L6 lysates (data not
shown). In these cells, E2F-2 was primarily nuclear in myo-
tubes, exhibiting very weak, albeit detectable cytoplasmic
staining. E2F-4 showed little specificity for a given com-
partment, being present in both the cytoplasm and in the
nucleus in myotubes. In contrast, E2F-1, E2F-3, and E2F-5
appeared exclusively cytoplasmic and were excluded from
the nuclei of myotubes. For E2F-1 and E2F-5, this local-
ization represents a major alteration, since these two fac-
tors were primarily nuclear in the exponentially growing
myoblasts. For E2F-3, little change in compartmentaliza-
tion was observed, this factor residing primarily in the cy-
toplasm throughout differentiation.
The studies previously examining the subcellular com-
partmentalization of the E2F family proteins have em-
ployed cells grown in culture. However, no data are pub-
lished describing their localization in situ. Therefore, we
Figure 1. E2F and pRB family members are compartmentalized during the cell cycle. (A) Rat-1 cells were growth-arrested in 0% serum
for 40 h, followed by addition of 10% serum. Cells were trypsinized and collected for FACS analysis at 4-h intervals after serum addi-
tion and proportions of cells in G0/G1, S phase, and G2/M were determined. The subcellular localization of E2F and pRB members was
determined by immunofluorescence as cells progress from G0 back into the cell cycle. Cells grown on coverslips, were removed at G0, S
phase, G2/M, and the subsequent G1, fixed in 2208C methanol, and immunostained with antibodies against E2F-1, E2F-4, pRB, and
p130. (B) The effect of a growth stimulus provided by low levels of growth factors on E2F subcellular localization was determined by ar-
resting L6 myoblasts in either 0% serum or in 0.2% serum for 40 h. Cells grown on coverslips were removed, fixed in 2208C methanol
and immunostained with antibodies against E2F-1 and E2F-4. Fixed cells are also visualized by light microscopy using Nomarski optics.
(C) The effect of an ectopic growth stimulus on subcellular localization during the cell cycle was examined by arresting cells in the pres-
ence of inducible cyclin D1. Cells grown on coverslips in the absence of tetracycline (induced cyclin D1) were removed, fixed in 2208C
methanol, and immunostained with antibodies against E2F-1, E2F-4, pRB, and p130. 
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wished to determine if the localization observed for the
E2Fs in differentiated cells grown in culture reflected their
compartmentalization in situ. Day E18.5 murine embryos
were sectioned and immunostained for E2F-1, E2F-4, or
the nuclear myogenic transcription factor, E47 (Fig. 3).
Skeletal muscle adjacent to the developing ribs revealed
E2F-4 immunofluorescence localized to the cytoplasm.
Areas within the cytoplasm that were devoid of E2F-4 sig-
nal (Fig. 3, arrowheads) coincided precisely to the DAPI-
stained nuclei, confirming E2F-4 exclusion from the nuclei
of muscle tissue. Likewise, E2F-1 staining was observed in
compartments distinct from the DAPI-stained nuclei. In
contrast to E2F-1 and E2F-4, immunostaining for the nu-
clear heterodimeric partner of the myogenic transcription
factor, E47, was coincident with the DAPI signal. Thus,
the localization observed for E2F-1 and E2F-4 in differen-
tiated muscle cells (myotubes) grown in culture reflects
their localization in embryonic muscle in situ.
 
LgT NLS Redirects E2F Localization in
Differentiated Myotubes
 
We next determined that high levels of exogenous E2F-1
and E2F-4 localize similarly to their endogenous counter-
parts in differentiated myotubes. Adenoviruses, express-
ing fusion proteins between GFP (Cormack et al., 1996)
and either E2F-1 or E2F-4, were used to infect multinucle-
ated myotubes at 5 
 
3
 
 10
 
9
 
 pfu (Fig. 4 A). 72 h after infec-
tion, GFP–E2F-1 was detected primarily in the cytoplasm
of myotubes, whereas GFP-E2F-4 is both nuclear and cy-
toplasmic, reflecting immunostaining results of the endog-
enous proteins. However, cytoplasmic sequestering of
these E2Fs could be overridden using the strong NLS from
SV40 LgT (Yang and DeFranco, 1994; Makkerh et al.,
1996; Xiao et al., 1997). The addition of this signal to ei-
ther GFP-tagged E2F-1 or E2F-4 resulted in their exclu-
sive nuclear localization. The subcellular localization of
the direct GFP fluorescent signal was confirmed by West-
ern analysis of fractionated lysates from infected myo-
tubes (Fig. 4 B). Specifically, all of the expressed GFP–
E2F-1 was detected in the cytoplasmic fraction, whereas
GFP–E2F-1 (NLS) was exclusively nuclear. GFP–E2F-4
was found in both the cytoplasm and the nucleus, whereas
addition of the NLS to this fusion protein caused exclusive
nuclear compartmentalization.
Given the exclusive nuclear localization of the NLS-
modified GFP–E2F-1 and GFP–E2F-4 fusion proteins, we
next sought to determine if nuclei of these infected cells
entered S phase. Differentiated cells were treated with
BrdU and simultaneously infected with either the GFP–
E2F-1 (NLS) or GFP–E2F-4 (NLS) viruses. 72 h later,
cells were fixed and BrdU incorporation determined. As
Fig. 5 indicates, despite the presence of high levels of the
GFP fusion proteins in the nuclei of these myotubes, very
rare nuclei stained positive for BrdU incorporation. Quan-
titation of GFP-expressing nuclei revealed, in fact, that
 
,
 
0.01% of nuclei expressing the strictly nuclear GFP–
E2F-1 (NLS) or GFP–E2F-4 (NLS) proteins stained for
BrdU.
However, the failure to drive nuclei into S phase was not
due to the inability of these fusion proteins to complex the
pRB family proteins or to an inability to bind DNA. Fig.
6 A demonstrates that immunoprecipitation of pRB re-
sulted in coimmunoprecipitation of GFP–E2F-1 and GFP–
E2F-1 (NLS). Furthermore, EMSAs demonstrated that
these fusion proteins could bind specifically to a double
stranded oligonucleotide encoding an E2F consensus se-
quence (Fig. 6 B). Addition of the antibody directed
against the HA tag on the exogenous GFP-tagged proteins
(Fig. 6 B, middle panel) confirmed the presence of these
fusion proteins in complexes binding the E2F site. In the
case of GFP–E2F-1 and GFP–E2F-1 (NLS), supershift as-
says using an antibody directed against pRB demonstrated
its presence in the GFP–E2F-1–containing complexes (Fig.
6 B, right panel).
Finally, we determined the expression pattern of known
E2F-1 target genes in myotubes infected with the various
GFP-tagged E2F fusion proteins. Using cyclin E as one
specific target, we determined that its expression was unal-
tered in the presence of the GFP-tagged E2Fs (Fig. 6 C).
Specifically, cyclin E is expressed at low but detectable
levels in myotubes. We compared cyclin E levels in GFP–
E2F expressing cells to its level in cells expressing the
dominant-negative cell cycle protein, pRB
 
D
 
p34/HA (lev-
els for the latter are identical to uninfected cells; data not
shown). In all cases, cyclin E levels were unchanged. Thus,
although the GFP–E2F fusion proteins bind pRB family
members, this activity is not sufficient to alter expression
of cell cycle regulatory factors or drive nuclei in postmi-
totic myotubes into S phase.
 
Nuclear Localization of Ectopic Wild-Type E2F-1 and 
E2F-4 Causes S Phase Entry of Nuclei in Terminally 
Differentiated Myotubes
 
Cytoplasmic sequestration of the E2Fs in terminally dif-
ferentiated myotubes suggests that this localization is one
mechanism preventing multinucleated myotubes from un-
dergoing additional rounds of DNA replication. There-
fore, we attempted to overcome the nuclear exclusion of
E2F-1 and E2F-4 in multinucleated myotubes by express-
ing increasing levels of these factors. L6 myotubes were in-
fected at 0.8 
 
3
 
 10
 
8
 
 (not shown), 4 
 
3
 
 10
 
8
 
, 2 
 
3
 
 10
 
9
 
, or 1 
 
3
 
10
 
10
 
 pfu with adenoviruses expressing wild-type E2F-1 or
E2F-4. Localization of E2F-1 and E2F-4 was determined
by indirect immunoflourescence using antibodies directed
against the specific E2Fs, whereas entry into S phase was
determined by BrdU incorporation (Fig. 7). In uninfected
myotubes, endogenous E2F-1 is cytoplasmic, whereas
E2F-4 is primarily cytoplasmic but with significant nuclear
localization. Infection with virus up to 4 
 
3
 
 10
 
8
 
 pfu resulted
in significant overexpression of ectopic E2F-1 and E2F-4
(approximately fourfold over endogenous by Western
analysis; Fig. 8). At this level of expression, the E2Fs local-
ized similarly to their endogenous counterparts in unin-
fected cells. Under these conditions, no nuclei in these
myotubes incorporated BrdU, indicating that they had not
entered S phase. However, infection at 2 
 
3
 
 10
 
9
 
 pfu or
greater caused the appearance of E2F-1 in the nucleus as
well as an increase in E2F-4 in this compartment. For both
E2Fs, the majority of nuclei in the terminally differenti-
ated myotubes had undergone DNA synthesis. In the case
of E2F-1, the occasional nuclei that did not stain for BrdU
were also devoid of signal for this E2F family member (see 
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Fig. 7, arrows in cells infected with 2 
 
3
 
 10
 
9
 
 pfu). Since
these nuclei were directly adjacent to nuclei that had un-
dergone DNA synthesis, it is apparent that entry into S
phase for individual nuclei was dependent on the presence
of E2F-1 in that nucleus and not due merely to expression
of other positive cell cycle regulatory factors (see below) in
the myotube. However, a block preventing mitosis is ap-
parent in these cells, since mitotic figures were never ob-
served in the BrdU-positive E2F-expressing cells.
S phase entry of E2F-1–expressing cells predicted that
alteration in expression of a number of cell cycle regula-
tory proteins and myogenic differentiation factors would
be observed. Thus, cell lysates prepared from the termi-
nally differentiated L6 cells infected with increasing levels
Figure 2 (continues on facing page). 
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of adenovirus expressing E2F-1 or E2F-4 were probed for
expression of a number of genes involved in mediating ei-
ther the G
 
1
 
–S transition or myogenic differentiation by
Western analysis (Fig. 8). Expression of either exogenous
E2F-1 or E2F-4 caused increased levels of pRB, the pro-
moter region of which encodes an E2F binding site (Shan
et al., 1994). pRB was also converted to its hyperphosphor-
 
ylated state at the highest level of multiplicity of infec-
tion, as would be expected for cells entering S phase. Con-
sistent with this change in the phosphorylation status of
pRB, cyclin A and cyclin E levels increased and the faster
migrating active form of cdk2 appeared. Furthermore, two
factors involved in the terminal differentiation of myo-
tubes, p21
 
Cip1
 
 and myogenin, are downregulated by ec-
Figure 2. E2F family mem-
bers are differentially se-
questered in the cytoplasm of
terminally differentiated myo-
tubes. The subcellular local-
ization of E2F and pRB fam-
ily members was examined
by immunofluorescence as
L6 myoblasts exit the cell cy-
cle and terminally differenti-
ate. Exponentially growing
L6 cells were plated at 20%
density and allowed to reach
confluence, when serum was
reduced to 2% (day 0) to
induce differentiation to
multinucleated postmitotic
myotubes. Coverslips were
removed from exponentially
growing cultures, as well as at
day 0, day 2, and day 5 after
serum reduction. (A–E) Un-
differentiated, day 0, day 2,
and day 5 cells were immu-
nostained with primary anti-
bodies against E2F-1, E2F-2,
E2F-3, E2F-4, and E2F-5 fol-
lowed by FITC-conjugated
secondary antibody. Nuclei
are visualized by DAPI stain-
ing and the corresponding
panels are presented be-
low the appropriate FITC-
labeled immunostained panel.
(F–H) Undifferentiated, day
0, day 2, and day 5 cells were
also immunostained with pri-
mary antibodies against pRB,
p107, and p130 followed by
FITC-conjugated secondary
antibody. Undifferentiated
cells are presented in the left-
hand panels, and terminally
differentiated multinucle-
ated myotubes in the right-
hand panels. 
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topic E2F-1 and E2F-4 expression, supporting the obser-
vation that E2F promotes cell cycle reentry of myotubes
while opposing the differentiation program.
 
Discussion
 
The levels of free E2F transcription complexes, unbound
by pRB family members, are strongly reduced as cells
leave the cell cycle during cellular differentiation (La
Thangue and Rigby, 1987; La Thangue et al., 1990; Shivji
and La Thangue, 1991; Corbeil et al., 1995; Kiess et al.,
1995; Shin et al., 1995; Gill et al., 1998), whereas expres-
sion of exogenous E2F-1 before differentiation blocks this
process (Wang et al., 1995, 1996; Guy et al., 1996; Guo and
Walsh, 1997; Strom et al., 1998). Subcellular compartmen-
talization is one of a number of overlapping mechanisms
involved in regulating E2F-dependent transcription (Lin-
deman et al., 1997; Muller et al., 1997; Verona et al., 1997).
This mechanism is analogous to the regulation of activity
of transcription factors such as TFIIIA (Fridell et al.,
1996), engrailed (Maizel et al., 1999), I
 
k
 
B
 
a
 
 (Fritz and
Green, 1996), and p53 (Stommel et al., 1999), which also
occur in part due to dynamic changes in their location
within a cell.
We demonstrated here that E2F-1 is localized in the cy-
toplasm of terminally differentiated myotubes, both in
vitro and in situ. In myotubes grown in culture, E2F-4 is
partitioned between the nucleus and the cytoplasm. How-
ever, at the stage of muscle development examined in
E18.5 embryos, E2F-4 appeared to be excluded from the
nucleus. E2F-3 and E2F-5 are also primarily cytoplasmic
in differentiated myotubes. p130 and pRB, which are in-
duced during myoblast differentiation (Kiess et al., 1995;
Yee et al., 1998), are detected primarily in the nuclei of
terminally differentiated myotubes. This localization for
the pRB family proteins in myotubes may reflect their in-
teraction with myogenic factors, which together promote
muscle differentiation (Gu et al., 1993; Novitch et al., 1996;
Skapek et al., 1996; Zacksenhaus et al., 1996; Sellers et al.,
1998). In contrast, our preliminary data examining their
Figure 3. E2F family members are localized in the cytoplasm of myotubes in the developing embryo. To determine whether cytoplas-
mic compartmentalization of the E2Fs occurs in vivo, sagittal sections of a murine day E18.5 embryo were immunostained against
E2F-1, E2F-4, and as a control, the nuclear myogenic transcription factor, E47. Skeletal muscle sections adjacent to the developing ribs
were probed with primary antibodies against E47, E2F-1, and E2F-4, followed by FITC-labeled secondary antibody. Nuclei are visual-
ized by DAPI staining. FITC and DAPI signals were determined by fluorescent microscopy and are presented individually and as a
combined FITC–DAPI image. Specific nuclei demonstrating nuclear immunostaining of E47 or nuclear exclusion of E2F-1 and E2F-4
are indicated by arrowheads. 
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localization during neuronal differentiation, indicate that
p130 and pRB reside in the cytoplasm of these terminally
differentiated cells (R.M. Gill, unpublished observation).
E2F-1, E2F-2, and E2F-3 encode an NH
 
2
 
-terminal NLS,
whereas E2F-4 and E2F-5 are deficient for this sequence.
 
These latter two E2F family proteins appear to rely on in-
teractions with DP family members or pRB family pro-
teins for their nuclear translocation (Lindeman et al., 1997;
Muller et al., 1997; Puri et al., 1998; Verona et al., 1997).
Although distinct in harbouring an NLS, all members of
the E2F family proteins encode a conserved domain that
resembles the leucine-rich nuclear export signals (NES) of
HIV-1 Rev protein (Fischer et al., 1995; R.M. Gill, unpub-
lished data). Interestingly, pRB, p107, and p130 also con-
tain potential NES consensus sequences in their NH
 
2
 
-ter-
minal domains (R.M. Gill, unpublished observation), a
region of p107 and p130 that is not otherwise well con-
served with pRB (Ewen et al., 1991; Hannon et al., 1993;
Li et al., 1993; Mayol et al., 1993; Sidle et al., 1996). The
Rev NES, which is similar to those of 
 
Xenopus TFIIA
(Fridell et al., 1996), rat protein kinase I (Fischer et al.,
1995; Wen et al., 1995), and murine IkBa (Arenzana-Seis-
dedos et al., 1997), is bound by CRM1 protein and trans-
ported to the cytoplasm (Fornerod et al., 1997). The pres-
ence of putative NES supports the notion that localization
of the E2F and pRB family proteins to the cytoplasm dur-
ing terminal differentiation may be due to an active export
mechanism. Recently, RanBP1, a factor that is involved in
nuclear import and export has been reported to be regu-
lated by E2F during the cell cycle (Di Fiore et al., 1999). It
contains two E2F binding sites in its promoter, a proximal
site responsible for repression of transcription during G0,
and a distal site that controls upregulation during S phase
(Di Fiore et al., 1999). RanBP1 contributes to nuclear im-
port by stabilizing the interaction of Ran with importin-b
(Chi et al., 1996; Lounsbury and Macara, 1997). It may
also be involved in transport from the nucleus to the cyto-
plasm by releasing CRM1 from the nuclear pore complex,
allowing the terminal step in nuclear export to occur
(Kehlenbach et al., 1999). It is interesting to speculate that
the cell cycle–dependent compartmentalization of E2F
and pRB family members may be regulated through a
feedback mechanism involving RanBP1.
We determined that differentiation-dependent cytoplas-
mic partitioning of the E2Fs could be overridden by clon-
ing the SV40 LgT NLS at the NH2 terminus of GFP-
tagged E2F-1 and E2F-4. These recombinant molecules,
when expressed in terminally differentiated myotubes using
an adenoviral vector, localized exclusively to the nucleus.
In the absence of the LgT NLS, exogenous GFP-tagged
E2F-1 and E2F-4 were primarily cytoplasmic, identical to
the distribution of endogenous protein as determined by
immunostaining. When targeted to the nuclei of terminally
differentiated myotubes, these GFP-tagged proteins did
not promote S phase entry, despite being capable of com-
plexing DNA, pRB, and cdk2. However, these GFP fusion
proteins were not active in inducing E2F target genes, sug-
gesting that the presence of either the large GFP moiety
and/or the LgT NLS at the NH2 termini of E2F-1 and E2F-4
was interfering with E2F-dependent activated transcrip-
tion. These results indicate that E2F-1 and E2F-4 do not
drive cells into S phase merely as a consequence of nuclear
translocation and sequestration of all the pRB family pro-
teins. Rather, progression into S appears to also require
activated transcription of E2F target genes.
When untagged versions of E2F-1 and E2F-4 were
expressed in differentiated myotubes at levels consider-
Figure 4. Ectopic GFP-tagged E2F-1 and E2F-4 localize to the
cytoplasm of myotubes and an ectopic NLS overcomes this com-
partmentalization. L6 cells were differentiated to multinucleated
myotubes in 2% serum for 72 h. Myotubes were then infected
with 5 3 109 pfu of adenovirus expressing GFP–E2F-1 or GFP–
E2F-4 fusion proteins, or GFP–E2F fusion proteins containing an
ectopic SV40 LgT NLS. GFP signals were determined by fluores-
cent microscopy using the FITC stimulation wavelength. (A) Im-
munofluorescence of GFP-tagged E2F-1 (left side) or E2F-4
(right side) proteins without (top) or with (bottom) the SV40
NLS were visualized by fluorescence microscopy. (B) Localiza-
tion of the GFP–E2F fusion proteins was also determined by
Western analysis of fractionated lysates from infected cells. Nu-
clear and cytoplasmic lysates from terminally differentiated L6
myotube cultures infected with adenoviral vectors expressing
GFP-tagged wild-type, or LgT NLS-tagged E2F-1 and E2F-4
were run on an SDS-PAGE gel and Western blotted with anti–
E2F-1 (left panel) and anti–E2F-4 (right panel) polyclonal anti-
bodies. Ectopic proteins are distinct from endogenous E2F due
to the 25-kD GFP moiety.The Journal of Cell Biology, Volume 148, 2000 1196
Figure 5. Nuclear targeted
GFP–E2F-1 and GFP–E2F-4
do not induce S phase in myo-
tubes. L6 cells were differen-
tiated to multinucleated myo-
tubes in 2% serum for 72 h.
Myotubes were then infected
with 5 3 109 pfu of adenovi-
rus expressing GFP–E2F-1
(NLS) or GFP–E2F-4 (NLS)
fusion proteins. 24 h after in-
fection, BrDU labeling re-
agent was added and the cells
were incubated for a further
48 h, at which point cells
grown on coverslips were
fixed, and nuclear and cyto-
plasmic lysates were pre-
pared. Immunofluorescence
of GFP-tagged E2F-1 (NLS)
(left panel) or E2F-4 (NLS)
(right panel) proteins was vi-
sualized by fluorescence mi-
croscopy using the FITC
stimulation wavelength. S
phase entry of GFP–E2F-
expressing cells was deter-
mined by anti-BrdU immu-
nohistochemistry using a
Texas red–labeled anti–
mouse secondary antibody.
Figure 6. GFP-tagged E2F molecules bind DNA and pRB family
proteins but have altered transactivation properties. (A) To de-
termine if endogenous pRB is capable of binding the GFP-tagged
E2F-1 fusion proteins, 3T3 cells were infected with 1 3 1010 pfu
of adenoviral vectors expressing GFP alone as well as GFP–E2F-
1/HA and GFP–E2F-1 (NLS)/HA. 400 mg of whole cell lysate
was immunoprecipitated with anti-pRB polyclonal antibody, and
coimmunoprecipitating GFP-tagged E2F was determined by
Western blotting with an anti-HA mAb. To determine whether
the cyclin A binding domain is accessible, ectopic GFP-tagged
E2F-1/HA and E2F-1 (NLS)/HA proteins, as well as a GFP con-
trol, were immunoprecipitated from adenoviral infected 3T3 ly-
sates with monoclonal anti-HA antibody, and coimmunoprecipi-
tating cdk2 protein was determined by anti-cdk2 Western blot
(right panel). (B) Nuclear lysate from 3T3 cells infected with ade-
noviral vectors expressing either untagged E2F-1, or GFP-tagged
wild-type, or NLS-tagged E2F-1 and E2F-4 was incubated at
room temperature for 10 min with a 32P end-labeled double-
stranded oligonucleotide probe containing a single E2F binding
site, before resolving on a 4.5% nondenaturing acrylamide gel.
The middle panel contains reactions in which 1 ml of monoclonal
anti-HA was added for an additional 10 min, whereas the right
panel contains reactions with anti-pRB monoclonal added. En-
dogenous E2F complexes are indicated, as are those containing
GFP-tagged E2F. A larger complex containing pRB as well as ec-
topic GFP-tagged E2F-1 is indicated by an asterisk. Note that a
mutant E2F molecule, which is deleted in the pRB-binding do-
main GFP–E2F-1DRbb/HA, does not form this pRB-containing
complex. (C) 3T3 cells were infected with 1 3 1010 pfu of ade-
noviral vectors expressing either untagged E2F-1, or GFP-tagged
wild-type, or NLS-tagged E2F-1 and E2F-4, as well as the pRB-
binding mutant GFP–E2F-1DRbb/HA, and 72 h after infection,
nuclear and cytoplasmic lysates were harvested and separated by
SDS-PAGE. Levels of endogenous cyclin E protein were deter-
mined by Western blot. Exogenous GFP-tagged proteins are de-
tected by an anti-HA monoclonal, and cdk4 is Western blotted as
a control for protein loading.Gill and Hamel Subcellular Localization of E2F during Myogenesis 1197
ably higher than that of their endogenous counterparts,
both E2F-1 and E2F-4 remain compartmentalized appro-
priately. There is a limit in the ability of the cell to main-
tain these transcription factors in the cytoplasm, however,
since very high levels of E2F-1 or E2F-4 become parti-
tioned between the cytoplasm and the nucleus. However,
it is clear that the mechanism(s) maintaining the E2F fam-
ily proteins in the cytoplasm in differentiated cells are very
robust and can tolerate a considerable increase in the lev-
els of these transcription factors.
It was interesting to note that both E2F-1 and E2F-4
were capable of driving myotube nuclei into S phase when
present in the nucleus at significant levels. For E2F-1,
these data are consistent with its ability to promote cell cy-
cle reentry of cardiac myocytes and cortical neurons (Suda
et al., 1994; Kirshenbaum et al., 1996) and that E2F-1 is
important for the transition from G0 to G1, but not for sub-
sequent cell cycles, as cells continue to proliferate (Leone
et al., 1998). Little data from differentiated cells exist for
the effect of E2F-4 on cell cycle progression. Here we
demonstrate that similar to E2F-1, E2F-4 induces expres-
sion of the positive cell cycle regulatory factors, cyclin A,
cyclin E, and cdk2 (Ohtsubo and Roberts, 1993; Resnitzky
et al., 1994, 1995; Wimmel et al., 1994; Duronio and O’Far-
Figure 7. Overexpression of ectopic E2F-1 and E2F-4 can overcome cytoplasmic sequestering and forces postmitotic myotube nuclei to
enter S phase. L6 cells were differentiated to multinucleated myotubes in 2% serum for 48 h. Myotubes were then infected with the
E2F-1 or E2F-4–expressing adenoviruses at either 0.8 3 108, 4 3 108, 2 3 109, or 1 3 1010 pfu, and 48 h after infection DNA synthesis
was determined by adding BrdU labeling reagent and incubating a further 24 h. Cells on coverslips were fixed and immunostained with
mAb against BrdU and a Texas red–labeled anti–mouse secondary antibody, as well as polyclonal antibodies against E2F-1, or E2F-4,
and FITC-labeled anti–rabbit secondary antibody. Nuclei were then stained with DAPI and each signal was captured by fluorescence
microscopy. FITC, Texas red, and DAPI signals for myotubes infected with adenovirus expressing E2F-1 are shown in the top panel,
whereas cells infected with E2F-4 adenovirus are shown in the bottom panel. Nuclei in Ad-E2F-1 infected cells (2 3 109 pfu), which do
not stain for BrdU or E2F-1, are indicated by arrowheads.The Journal of Cell Biology, Volume 148, 2000 1198
rell, 1995; Ohtsubo et al., 1995; Resnitzky and Reed, 1995;
Rosenberg et al., 1995; Chen et al., 1996; Duronio et al.,
1996), represses factors required for muscle differentia-
tion, such as myogenin and p21 (Edmondson and Olson,
1989; Wright et al., 1989; Guo et al., 1995; Missero et al.,
1995), and promotes S phase entry. However, although
postmitotic nuclei in myotubes are capable of responding
to an E2F-1 and E2F-4–mediated proliferative stimulus, a
block preventing mitosis is evident in these nuclei since
mitotic figures are never observed in the infected myo-
tubes. These data for E2F-1 and E2F-4 are reminiscent of
the effect of deregulated E2F activity in pRB-deficient an-
imals. Specifically, expression of a weak allele of pRB on
the pRB-null background resulted in progression of mus-
cle differentiation (Zacksenhaus et al., 1996). However, in
these muscles, abundant large nuclei were present that had
undergone several rounds of endoreduplication, whereas
mitosis was not observed. The nature of this block in mi-
totic entry is currently under investigation.
The ability of exogenous nuclear-localized E2F-1 and
E2F-4 to induce S phase appears to be linked to their abil-
ity to properly regulate the transcription of E2F target
genes. GFP-tagged E2F, even if targeted to the nucleus by
an ectopic NLS, was unable to cause postmitotic myotube
nuclei to enter S phase. These GFP-tagged molecules were
able to bind DNA and pRB family members, but have al-
tered transactivation properties. This would suggest that it
is their failure to appropriately regulate expression of E2F
target genes that is the cause of their defect in S phase in-
duction.
It has been reported previously that E2F-4 is nuclear
during a reversible G0 arrest of Rat-1 fibroblasts and shifts
to the cytoplasm as cells pass into S phase (Muller et al.,
1997). However, we detected E2F-4 in the cytoplasm of se-
rum-starved Rat-1 fibroblasts, followed by nuclear com-
partmentalization as cells reenter the cell cycle. The prin-
ciple discrepancy in these data occurs in cells arrested in
low serum. We observed that cytoplasmic compartmental-
ization of E2F occurs when both fibroblasts, as well as
undifferentiated myoblasts, are arrested in 0.0% serum.
However, when the same cells were arrested using 0.2%
serum, we observed nuclear staining for the E2Fs. We hy-
pothesized that even a very weak mitogenic stimulus (e.g.,
0.2% serum) was sufficient to alter the subcellular local-
ization of the cell cycle regulatory factors. This hypothesis
was supported by our observation that tetracycline-depen-
dent expression of cyclin D1 in serum-starved Rat-1 cells
caused nuclear localization of E2F-4 and E2F-1. It is inter-
esting to speculate that cytoplasmic localization of E2F in
the complete absence of growth factors is analogous to
their cytoplasmic localization in terminally differentiated
myotubes, which are incapable of responding to growth
stimuli.
In conclusion, we have shown that E2F family members,
E2F-1, E2F-3, E2F-5, and to a lesser extent E2F-4, are se-
questered in the cytoplasm during the G0 arrest associated
with terminal differentiation of muscle. These postmitotic
nuclei are still capable of reentering the cell cycle upon an
E2F-1– or E2F-4–mediated proliferation stimulus, indicat-
ing that cytoplasmic compartmentalization of E2F-1 and
E2F-4 is necessary in order to maintain nuclei in a quies-
cent state in terminally differentiated cells.
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